Very-low-dose ketamine for the management of pain and sedation in the ICU

Journal of Opioid Management

Volumn 4, Issue 1, 2008, Pages 54-56

  De Pinto, Mario ^a   Jelacic, Jill ^a   Edwards, William T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Critical care; Opioids; Pain; Sedation; Tolerance

Indexed keywords

ANTICOAGULANT AGENT; FENTANYL; HEPARIN; KETAMINE; LORAZEPAM; METHADONE; MORPHINE; OXYCODONE; PROPOFOL;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CARDIOVERSION; CASE REPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTINUOUS HEMOFILTRATION; CORONARY ARTERY DISEASE; DRUG DOSE INCREASE; FEMUR FRACTURE; FRACTURE FIXATION; HEART ATRIUM FIBRILLATION; HUMAN; LOW DRUG DOSE; MALE; OBESITY; PAIN; SEDATION; TIBIA FRACTURE; TRAFFIC ACCIDENT;

EID: 41549129870     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2008.0009     Document Type: Article

References (16)

1. Whipple JK, Lewis KS, Quebberman EJ, et al.: Analysis of pain management in critically ill patients. Pharmacotherapy. 1995; 15: 592-599.
2. Cohen S, Christo P, Moroz L: Pain management in trauma patients. Am J Phys Med Rehabil. 2004; 83(2): 142-161.
3. Jacob E, Puntillo K: Variability of analgesic practices for hospitalized children on different pediatric specialty units. J Pain Symptom Manage. 2000; 20: 59-67.
4. Eilers H, Philip LA, Bickler PE, McKay WR, Schumacher MA: The reversal of fentanyl-induced tolerance by administration of "small dose" ketamine. Anesth Analg. 2001; 93: 213-244.
5. Gonzales P, Cabello P, Germany A, et al.: Decrease of tolerance to, and physical dependence on morphine by glutamate receptor antagonists. Eur J Pharmacol. 1997; 332: 257-262.
6. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain. 1995; 62: 259-74.
7. Mercadante S, Lodi F, Sapio M, et al.: Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage. 1995; 10: 564-568.
8. Bell RF: Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain. 1999; 83: 101-103.
9. White PF, Way WL, Trevor AJ: Ketamine - Its pharmacology and therapeutic uses. Anesthesiology. 1982; 56: 119-136.
10. Eide PK, Stubaugh A, Oye I, Breivik H: Continuous subcutaneous administration of NM-methyl-Daspartic acid (NMDA) receptor antagonist ketamine in the treatment of postherpetic neuralgia. Pain. 1995; 61: 221-228.
11. Stannard CF, Porter GE: Ketamine hydrochloride in the treatment of phantom limb pain Pain. 1993; 54: 227-230.
12. Persson J, Axelsson G, Hallin RG, Gustafsson LL: Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization Pain. 1995; 60: 217-222.
13. Lauretti GR, Lima ICPR, Reis MP, et al.: Oral ketamine and transdermal nitroglycerine as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology. 1999; 90: 1528-1533.
14. Kannan TR, Saxena A, Bhatnagar S, Barry A: Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage. 2002; 23(1): 60-65.
15. Joachimsson PO, Heldstrand U, Eklund A: Low dose ketamine infusion for analgesia during postoperative ventilator treatment. Acta Anesthesiol Scand. 1986; 30(8): 697-702.
16. Edrich T, Friedrich AD, Eltzschig HK, Felbinger TW: Ketamine for long term sedation and analgesia of a burn patient. Anesth Analg. 2004; 99(3): 893-895.